Joel Taubin
Pulmonary Disease · Washington, DCNPI 1295703791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations.
Across 105 payments — averaging $15.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$284
- Pfizer$280
- AstraZeneca$262
- Amgen$174
- AbbVie$174
- Johnson & Johnson$164
- plus $336 from 12 others
What the payments were for
- Food & beverage$1,674100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 23 | $284 |
| Pfizer | 15 | $280 |
| AstraZeneca | 16 | $262 |
| Amgen | 11 | $174 |
| AbbVie(2 entities) | 11 | $174 |
| Johnson & Johnson(2 entities) | 8 | $164 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| Lilly USA, LLC | 3 | $47 |
| Novartis | 2 | $42 |
| Boehringer Ingelheim | 2 | $36 |
| Bausch Health US, LLC | 1 | $26 |
| Hikma Pharmaceuticals USA | 2 | $24 |
| Bristol Myers Squibb | 2 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
| Aytu Biopharma, Inc. | 1 | $11 |
How this compares
$1,674 in reported general payments places this provider in the 65th percentile of 56 pulmonary disease providers in District of Columbia.
See all pulmonary disease providers in District of Columbia →
Other pulmonary disease in Washington
- Andrew ShorrWashington$349K
- Eric AndersonWashington$215K
- Anne OdonnellWashington$61K
- Andrew LernerWashington$19K
- Guillermo GutierrezWashington$14K
- Khalil DiabWashington$10K
- Lorenzo LeysWashington$9K
- Rebecca KrochmalWashington$9K
- Steven LernerWashington$6K
- Karen FaganWashington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.